Jobs associated with higher economic status appear to be risk factors for these neurologic disorders.
AC Immune SA Shares Phase 2 VacSYn Trial Update for ACI-7104.056 in Parkinson Disease
Episode 108: Advancing the Genetic Pool of Parkinson Disease
Parkinson Disease Smartphone Speech Metric Analysis Shows Clinical Validity in Phase 2 PASADENA Trial
Paradigm Shift in Parkinson’s Disease Diagnosis
NeurologyLive® Brain Games: March 24, 2024
Health Care Avoidance and Neurological Needs in Transgender and Gender-Diverse Patients